Gastrointestinal cancers Flashcards
CRC incidence
2nd most common new cancer
3rd most common cancer death
> 50% in >70yrs of age
Curable when localised
5yr survival 63%
Staging of CRC
Dukes 1 = Submucosal 2 = through serosa 3 = regional lymph nodes 4 = distant mets
Prognostic factors of CRC
DEPTH OF PENETRATION- deeper = poorer Serosal involvement = poor LN involvement = poor Distant mets = poor Bowel obstruction/perforation Extramural LVI
MSI = improved survival
Risk factors CRC
Age >50yrs Family history Poor intake of fruits and vegetables EtOH Obesity T2DM IBD
Familial CRC?
FAP:
- APC germline mutation
- <1% of CRCs
- CRC by 45yrs
HNPCC:
- Defects in mismatch repair genes - MSH2 and MSH6, MLH1 and MLH3, PMS1 and PMS2
- 2-4% of CRC
- CRC and endometrical cancer
Screening for low risk:
- asymptomatic individuals without personal history of IBD or CRC or family history of CRC
98% of population
FOBT every 5yrs from 50yrs
Screening for moderately increased risk:
- 1st degree relative <55yrs CRC
- 2 relatives with CRC any age
5yrly Colonoscopy from 50yrs OR 10yrs younger than 1st diagnosis of CRC
Screening for high risk:
- > 3 relative with CRC
- > 2 relative and multiple CRCs in 1 person
- CRC <50yrs and endometrial or ovarian cancer
- Suspected FAP in family
- Suspected HNPCC in family
Need genetic counseling ? FAP or HNPCC
FAP:
- Sigmoidoscopy from 12yrs
- Colectomy 25yrswith duodenal screening yrly
HNPCC:
- Colonoscopy yrly from 25yrs
Adjuvant chemotherapy
If lymph node disease present = Chemotherapy
5FU or capecitabine +oxaliplatin
5FU
5-Fluorouracil
Antimetabolite - pyrimidine analogue
Given with folinic acid
Side effects:
- Lethargy, N+V
- Cardiac toxicity - coronary vasospasm
- Diarrhoea
- Mucositis
- Palmar and plantar erythema
Worse is dihydropyrimidine dehydrogenase deficit
Capecitabine
Fluoropyrimidine
Similar side efects to 5FU but more palmar plantar erythema
Oxaliplatin
Platinum derivative
Side effects:
- Lethargy
- N+V+D
- Myelosuppression
- Peripheral neuropathy
Treatment for metastatic CRC
Chemotherapy - 5FU/capecitabine+oxaliplatin
K-RAS wild type = Bevacizumab and chemotherapy
Fail 1st line and K-RAS wildtype = Cetuximab +/- chemo
Liver metastasis in CRC
If liver only mets = resect
Neo-adjuvant chemo may result in resectable margins
Rectal cancer treatment
Neoadjuvant chemo and radio
Surgery